An overview of prognostic factors for long-term survivors of breast cancer

[1]  A. Wolk,et al.  Body weight and postmenopausal breast cancer risk defined by estrogen and progesterone receptor status among Swedish women: A prospective cohort study , 2006, International journal of cancer.

[2]  H. Verkooijen,et al.  Social class is an important and independent prognostic factor of breast cancer mortality , 2006, International journal of cancer.

[3]  T. Whelan,et al.  Influence of hospital characteristics on operative death and survival of patients after major cancer surgery in Ontario. , 2006, Canadian journal of surgery. Journal canadien de chirurgie.

[4]  M. García-Closas,et al.  Established breast cancer risk factors by clinically important tumour characteristics , 2006, British Journal of Cancer.

[5]  S. Shak,et al.  A population-based study of tumor gene expression and risk of breast cancer death among lymph node-negative patients , 2006, Breast Cancer Research.

[6]  C. Hogue,et al.  Multiple primary tumours in women following breast cancer, 1973–2000 , 2006, British Journal of Cancer.

[7]  Irene L Andrulis,et al.  HER2 and responsiveness of breast cancer to adjuvant chemotherapy. , 2006, The New England journal of medicine.

[8]  C. Geyer,et al.  Prognosis after ipsilateral breast tumor recurrence and locoregional recurrences in five National Surgical Adjuvant Breast and Bowel Project node-positive adjuvant breast cancer trials. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[9]  P. V. van Diest,et al.  Long‐term survival of T1 and T2 lymph node‐negative breast cancer patients according to mitotic activity index: A population‐based study , 2006, International journal of cancer.

[10]  D. Slamon,et al.  Docetaxel, cisplatin, and trastuzumab as primary systemic therapy for human epidermal growth factor receptor 2-positive locally advanced breast cancer. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[11]  H Brenner,et al.  Higher long-term cancer survival rates in southeastern Netherlands using up-to-date period analysis. , 2006, Annals of oncology : official journal of the European Society for Medical Oncology.

[12]  J. Prichard,et al.  Breast cancer in elderly women: outcome as affected by age, tumor features, comorbidities, and treatment approach. , 2006, Clinical breast cancer.

[13]  G. Colditz,et al.  Meta-analysis of survival in African American and white American patients with breast cancer: ethnicity compared with socioeconomic status. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[14]  J. Klijn,et al.  Cause-specific mortality in long-term survivors of breast cancer: A 25-year follow-up study. , 2006, International journal of radiation oncology, biology, physics.

[15]  R W Blamey,et al.  Prognostic value of lymphovascular invasion in women with lymph node negative invasive breast carcinoma. , 2006, European journal of cancer.

[16]  R. Collins,et al.  Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials , 2005, The Lancet.

[17]  A. Leclerc,et al.  Social inequalities in breast cancer mortality among French women: disappearing educational disparities from 1968 to 1996 , 2005, British Journal of Cancer.

[18]  D. Wickerham,et al.  Effects of obesity and race on prognosis in lymph node-negative, estrogen receptor-negative breast cancer , 2006, Breast Cancer Research and Treatment.

[19]  T. Byers,et al.  A Weight Loss Trial for Breast Cancer Recurrence: Pre-Menopausal, Post-Menopausal, Both, or Neither? , 2006, Cancer Causes & Control.

[20]  F. Hu,et al.  Dietary patterns and survival after breast cancer diagnosis. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[21]  Graham A Colditz,et al.  Alcohol and postmenopausal breast cancer risk defined by estrogen and progesterone receptor status: a prospective cohort study. , 2005, Journal of the National Cancer Institute.

[22]  M. J. van de Vijver,et al.  Long-term prognosis of patients with local recurrence after conservative surgery and radiotherapy for early breast cancer. , 2005, European journal of cancer.

[23]  Y. Maehara,et al.  The time-related changes of the importance of prognostic factors in breast cancer. A sequential multivariate analysis of 1423 Japanese patients , 2005, Breast Cancer Research and Treatment.

[24]  E. Yu,et al.  Short- and long-term cause-specific survival of patients with inflammatory breast cancer , 2005, BMC Cancer.

[25]  Greg Yothers,et al.  Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer. , 2005, The New England journal of medicine.

[26]  D. Nerenz,et al.  Comorbidity and survival disparities among black and white patients with breast cancer. , 2005, JAMA.

[27]  R. Gelber,et al.  Meeting highlights: international expert consensus on the primary therapy of early breast cancer 2005. , 2005, Annals of oncology : official journal of the European Society for Medical Oncology.

[28]  Yu Shen,et al.  Role of detection method in predicting breast cancer survival: analysis of randomized screening trials. , 2005, Journal of the National Cancer Institute.

[29]  Y Wang,et al.  Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials , 2005, The Lancet.

[30]  P. Bonnier,et al.  Comparison of the prognosis indication of VEGFR-1 and VEGFR-2 and Tie2 receptor expression in breast carcinoma. , 2005, International journal of oncology.

[31]  J. Coebergh,et al.  Less extensive treatment and inferior prognosis for breast cancer patient with comorbidity: a population-based study. , 2005, European journal of cancer.

[32]  J. Ferlay,et al.  Global Cancer Statistics, 2002 , 2005, CA: a cancer journal for clinicians.

[33]  S. Tretli,et al.  Weak associations between sociodemographic factors and breast cancer: possible effects of early detection , 2005, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.

[34]  Darrell N. Smith,et al.  Prognosis after local recurrence after conservative surgery and radiation for early-stage breast cancer. , 2005, International journal of radiation oncology, biology, physics.

[35]  G. Colditz.  Estrogen, estrogen plus progestin therapy, and risk of breast cancer. , 2005, Clinical cancer research : an official journal of the American Association for Cancer Research.

[36]  Graham A Colditz,et al.  Physical activity and survival after breast cancer diagnosis. , 2004, JAMA.

[37]  B. Haffty,et al.  Clinicopathologic features and long-term outcome of patients with medullary breast carcinoma managed with breast-conserving therapy (BCT). , 2003, International journal of radiation oncology, biology, physics.

[38]  A. Patchefsky,et al.  Interobserver reproducibility of histopathological features in stage II breast cancer , 1985, Breast Cancer Research and Treatment.

[39]  K. Zedeler,et al.  Correlation of growth fraction by Ki-67 and proliferating cell nuclear antigen (PCNA) immunohistochemistry with histopathological parameters and prognosis in primary breast carcinomas , 2005, Breast Cancer Research and Treatment.

[40]  I. Ellis,et al.  The Nottingham prognostic index in primary breast cancer , 2005, Breast Cancer Research and Treatment.

[41]  N. Wolmark,et al.  Treatment of axillary lymph node-negative, estrogen receptor-negative breast cancer: updated findings from National Surgical Adjuvant Breast and Bowel Project clinical trials. , 2004, Journal of the National Cancer Institute.

[42]  J. Bryant,et al.  Treatment of lymph-node-negative, oestrogen-receptor-positive breast cancer: long-term findings from National Surgical Adjuvant Breast and Bowel Project randomised clinical trials , 2004, The Lancet.

[43]  V. Kataja,et al.  Risk for distant recurrence of breast cancer detected by mammography screening or other methods. , 2004, JAMA.

[44]  Michael Gnant,et al.  Prognostic Value of Lymphangiogenesis and Lymphovascular Invasion in Invasive Breast Cancer , 2004, Annals of surgery.

[45]  F. Akiyama,et al.  Improvement in the prognosis of Japanese breast cancer patients from 1946 to 2001--an institutional review. , 2004, Japanese journal of clinical oncology.

[46]  A. Goldhirsch,et al.  Body mass index as a prognostic feature in operable breast cancer: the International Breast Cancer Study Group experience. , 2004, Annals of oncology : official journal of the European Society for Medical Oncology.

[47]  J. Coebergh,et al.  Comorbidity has negligible impact on treatment and complications but influences survival in breast cancer patients , 2004, British Journal of Cancer.

[48]  S. Chia,et al.  Ten-year outcomes in a population-based cohort of node-negative, lymphatic, and vascular invasion-negative early breast cancers without adjuvant systemic therapies. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[49]  J. Coebergh,et al.  Using loco-regional recurrence as an indicator of the quality of breast cancer treatment. , 2004, European journal of cancer.

[50]  Hermann Brenner,et al.  Are patients diagnosed with breast cancer before age 50 years ever cured? , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[51]  H Brenner,et al.  Period analysis for 'up-to-date' cancer survival data: theory, empirical evaluation, computational realisation and applications. , 2004, European journal of cancer.

[52]  P. Bonnier,et al.  Long-term prognostic significance of neoangiogenesis in breast carcinomas: comparison of Tie-2/Tek, CD105, and CD31 immunocytochemical expression. , 2004, Human pathology.

[53]  T. Nishikawa,et al.  Blood Vessel Invasion as a Predictor of Long-Term Survival for Japanese Patients with Breast Cancer , 2002, Breast Cancer Research and Treatment.

[54]  T. Nishikawa,et al.  Angiogenesis as a predictor of long-term survival for 377 Japanese patients with breast cancer , 2001, Breast Cancer Research and Treatment.

[55]  F Berrino,et al.  EUROCARE-3: survival of cancer patients diagnosed 1990-94--results and commentary. , 2003, Annals of oncology : official journal of the European Society for Medical Oncology.

[56]  J. Satagopan,et al.  A combined analysis of outcome following breast cancer: differences in survival based on BRCA1/BRCA2 mutation status and administration of adjuvant treatment , 2003, Breast Cancer Research.

[57]  E. Mamounas,et al.  Obesity, tamoxifen use, and outcomes in women with estrogen receptor-positive early-stage breast cancer. , 2003, Journal of the National Cancer Institute.

[58]  Tim Byers,et al.  Nutrition and Physical Activity During and After Cancer Treatment: An American Cancer Society Guide for Informed Choices , 2003, CA: a cancer journal for clinicians.

[59]  Philip M. Long,et al.  Breast cancer classification and prognosis based on gene expression profiles from a population-based study , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[60]  F. Bray,et al.  Breast cancer incidence and mortality trends in 16 European countries. , 2003, European journal of cancer.

[61]  D. Forman,et al.  Surgeon workload and survival from breast cancer , 2003, British Journal of Cancer.

[62]  Larry Norton,et al.  Natural history of more than 20 years of node-positive primary breast carcinoma treated with cyclophosphamide, methotrexate, and fluorouracil-based adjuvant chemotherapy: a study by the Cancer and Leukemia Group B. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[63]  J. Hendriks,et al.  Initiation of population-based mammography screening in Dutch municipalities and effect on breast-cancer mortality: a systematic review , 2003, The Lancet.

[64]  L. Tabár,et al.  Mammography service screening and mortality in breast cancer patients: 20-year follow-up before and after introduction of screening , 2003, The Lancet.

[65]  J. Ragaz,et al.  Long-term survival of patients with supraclavicular metastases at diagnosis of breast cancer. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[66]  Richard J. K. Taylor,et al.  Long-term survival of women with breast cancer in New South Wales. , 2003, European journal of cancer.

[67]  Yudong D. He,et al.  A Gene-Expression Signature as a Predictor of Survival in Breast Cancer , 2002 .

[68]  L. Belghiti,et al.  Prognostic factors in breast cancer , 2002 .

[69]  C. Hill,et al.  Prediction of the long‐term survival in breast cancer patients according to the present oncological status , 2002, Statistics in medicine.

[70]  S. Costa,et al.  Factors influencing the prognostic role of oestrogen and progesterone receptor levels in breast cancer--results of the analysis of 670 patients with 11 years of follow-up. , 2002, European journal of cancer.

[71]  Ingvar Andersson,et al.  Long-term effects of mammography screening: updated overview of the Swedish randomised trials , 2002, The Lancet.

[72]  T. Nishikawa,et al.  p53, mitosis, apoptosis and necrosis as prognostic indicators of long-term survival in breast cancer. , 2002, Anticancer research.

[73]  M. Campiglio,et al.  HER-2-positive breast carcinomas as a particular subset with peculiar clinical behaviors. , 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.

[74]  M Bracko,et al.  Long term prognostic value of Nottingham histological grade and its components in early (pT1N0M0) breast carcinoma. , 2002, Journal of clinical pathology.

[75]  Yudong D. He,et al.  Gene expression profiling predicts clinical outcome of breast cancer , 2002, Nature.

[76]  S. Singletary,et al.  Prognostic Factors in Node-Negative Breast Cancer: A Review of Studies With Sample Size More Than 200 and Follow-Up More Than 5 Years , 2002, Annals of surgery.

[77]  I. Ellis,et al.  Prognostic significance of synchronous and metachronous bilateral breast cancer , 2001, World journal of surgery.

[78]  P. Kyyrönen,et al.  Survival of breast cancer patients in BRCA1, BRCA2, and non‐BRCA1/2 breast cancer families: A relative survival analysis from Finland , 2001, International journal of cancer.

[79]  A. Vincent-Salomon,et al.  Long term outcome of small size invasive breast carcinomas independent from angiogenesis in a series of 685 cases , 2001, Cancer.

[80]  A. Thor,et al.  Measures of cell turnover (proliferation and apoptosis) and their association with survival in breast cancer. , 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.

[81]  D. Hole,et al.  Prognostic factors in women with breast cancer: distribution by socioeconomic status and effect on differences in survival , 2001, Journal of epidemiology and community health.

[82]  B Fisher,et al.  Fifteen‐year prognostic discriminants for invasive breast carcinoma , 2001, Cancer.

[83]  C. Giardina,et al.  Prognostic factors in breast cancer: the predictive value of the Nottingham Prognostic Index in patients with a long-term follow-up that were treated in a single institution. , 2001, European journal of cancer.

[84]  G. Vorgias,et al.  Prognostic significance of factors affecting disease free interval and overall survival for Stage II breast cancer in Greece. A multivariate cohort study. , 2001, European journal of obstetrics, gynecology, and reproductive biology.

[85]  S. Martino,et al.  Prediction of Node-Negative Breast Cancer Outcome by Histologic Grading and S-Phase Analysis by Flow Cytometry: An Eastern Cooperative Oncology Group Study (2192) , 2001, American journal of clinical oncology.

[86]  R. Gelber,et al.  Tubular carcinoma of the breast: Prognosis and response to adjuvant systemic therapy , 2001, ANZ journal of surgery.

[87]  F. Spyratos,et al.  Relationship between c-erbB-2 and other tumor characteristics in breast cancer prognosis. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

[88]  S. Edge,et al.  Prognostic factors in breast cancer , 2005 .

[89]  D. Fischer,et al.  Second malignancies after treatment of early-stage breast cancer: lumpectomy and radiation therapy versus mastectomy. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[90]  R. Gelber,et al.  Is chemotherapy alone adequate for young women with oestrogen-receptor-positive breast cancer? , 2000, The Lancet.

[91]  Mike Clarke,et al.  UK and USA breast cancer deaths down 25% in year 2000 at ages 20–69 years , 2000, The Lancet.

[92]  A. Ramaioli,et al.  P53 determination alongside classical prognostic factors in node-negative breast cancer: an evaluation at more than 10-year follow-up. , 2000, Annals of oncology : official journal of the European Society for Medical Oncology.

[93]  R. Riffenburgh,et al.  Survival of patients with untreated breast cancer , 2000, Journal of surgical oncology.

[94]  P. Andersen,et al.  Factors influencing the effect of age on prognosis in breast cancer: population based study , 2000, BMJ : British Medical Journal.

[95]  J. Nesland,et al.  The prognostic value of p53 and c‐erb b‐2 immunostaining is overrated for patients with lymph node negative breast carcinoma , 2000, Cancer.

[96]  P. Houts,et al.  ACS cancer facts and figures , 2000 .

[97]  W. Willett,et al.  Dietary factors and the survival of women with breast carcinoma , 1999, Cancer.

[98]  R. Coombes,et al.  Outcome of primary-breast-cancer patients with micrometastases: a long-term follow-up study , 1999, The Lancet.

[99]  W. Hepburn,et al.  14 years of follow-up from the Edinburgh randomised trial of breast-cancer screening , 1999, The Lancet.

[100]  I. Ellis,et al.  The prognosis of small primary breast cancers. , 1999, European journal of cancer.

[101]  S. Tsutsui,et al.  Prognostic impact of second cancer on the survival of early breast cancer patients. , 1999, International journal of oncology.

[102]  A. Jemal,et al.  Global cancer statistics , 2011, CA: a cancer journal for clinicians.

[103]  S. Pinder,et al.  The importance of the histologic grade of invasive breast carcinoma and response to chemotherapy , 1998, Cancer.

[104]  K Vajda,et al.  [Prognostic factors in breast cancer]. , 1998, Orvosi hetilap.

[105]  C. Lewis,et al.  Response to radiation therapy and prognosis in breast cancer patients with BRCA1 and BRCA2 mutations. , 1998, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[106]  B. Wójcik,et al.  Breast carcinoma survival analysis for african american and white women in an equal‐access health care system , 1998, Cancer.

[107]  S. Tretli,et al.  Long-term survival of breast cancer in Norway by age and clinical stage. , 1997, Statistics in medicine.

[108]  I. Ellis,et al.  Early-onset breast cancer--histopathological and prognostic considerations. , 1997, British Journal of Cancer.

[109]  D. Wartenberg,et al.  The importance of histologic type on breast cancer survival. , 1997, Journal of clinical epidemiology.

[110]  R. Hiatt,et al.  Comorbidity and breast cancer survival: a comparison between black and white women. , 1996, Annals of epidemiology.

[111]  E. Feuer,et al.  The impact of stage and histology on the long‐term clinical course of 163,808 patients with breast carcinoma , 1996, Cancer.

[112]  V. Kosma,et al.  Expression of p53 protein has no independent prognostic value in breast cancer , 1995, The Journal of pathology.

[113]  G. Jacobsen,et al.  An immunohistochemical study of p53 with correlations to histopathological parameters, c-erbB-2, proliferating cell nuclear antigen, and prognosis. , 1995, Human pathology.

[114]  K. Zedeler,et al.  Proliferating cell nuclear antigen (pcna) and C-erbb-2 oncoprotein in breast-carcinoma with correlations to histopathological parameters and prognosis. , 1995, Oncology reports.

[115]  Steven E. Bayer,et al.  A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. , 1994, Science.

[116]  F. Rosato,et al.  Diseases of the Breast , 1972 .

[117]  E T BELL,et al.  The Diseases of the Breast , 1925, Nature.